NIH researchers make progress toward Epstein-Barr virus vaccine

(NIH/National Institute of Allergy and Infectious Diseases) A research team led by scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) has determined how several antibodies induced by Epstein-Barr virus (EBV), a herpesvirus that causes infectious mononucleosis and is associated with certain cancers, block infection of cells grown in the laboratory. They then used this information to develop novel vaccine candidates that, in animals, elicited potent anti-EBV antibody responses that blocked infection of cell types involved in EBV-associated cancers.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news